title: BRCA2-associated therapy-related acute myeloid leukemia.
authors.affiliation: Division of Oncology, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8056, St. Louis, MO, 63110, USA, arashidi@dom.wustl.edu.
authors.forename: Armin
authors.initials: A
authors.lastname: Rashidi
authors.forename: Ina
authors.initials: I
authors.lastname: Amarillo
authors.forename: Stephen I
authors.initials: SI
authors.lastname: Fisher
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000235:genetics; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000235:genetics; D003520:Cyclophosphamide / Q000009:adverse effects; D000077143:Docetaxel; D015251:Epirubicin / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D024522:Genes, BRCA2; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000235:genetics; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000235:genetics; D043823:Taxoids / Q000009:adverse effects
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil